HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹373 Cr | ₹367 Cr | ₹423 Cr | ₹490 Cr | ₹287 Cr |
What is the latest Secured Loans ratio of HIKAL ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹373 Cr |
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹423 Cr |
| Mar2023 | ₹490 Cr |
| Mar2022 | ₹287 Cr |
How is Secured Loans of HIKAL Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹373 Cr | 1.61 | |
| Mar2025 | ₹367 Cr | -13.17 | |
| Mar2024 | ₹423 Cr | -13.67 | |
| Mar2023 | ₹490 Cr | 70.88 | |
| Mar2022 | ₹287 Cr | - | |
Compare Secured Loans of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,720.6 Cr | 9.1% | 1.3% | -12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 9.1% |
1.3% |
-12.8% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses